Omeros (OMER) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $18.79, +1.95% vs the prior close of $18.43.
- Volume 931.40K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
OMER rises 2.0% to $18.79. Closed at $18.79, +1.95% vs the prior close of $18.43. Day range $18.30–$19.08, opened at $18.50.
OMER daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — OMER rises 2.0% to $18.79
- Closed at $18.79, +1.95% vs the prior close of $18.43. Day range $18.30–$19.08, opened at $18.50.
- Volume was 931.40K shares, 0.5x its 50-day average of 1.76M — lighter than usual.
- Price is +3.1% vs its 50-day average ($18.23) and +40.9% vs its 200-day average ($13.34).
- 52-week range $6.24–$21.24; today's close sits at 84% of that range, 11.5% below the 52-week high.
Oct 14, 2026 — OMER dips 2.4% to $18.43, 3 down days in a row
- Closed at $18.43, -2.38% vs the prior close of $18.88. Day range $18.39–$19.27, opened at $18.58.
- Volume was 904.90K shares, 0.5x its 50-day average of 1.78M — lighter than usual.
- Price is +1.8% vs its 50-day average ($18.11) and +38.3% vs its 200-day average ($13.33).
- 52-week range $4.06–$21.24; today's close sits at 84% of that range, 13.2% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — OMER slides 3.8% to $18.88
- Closed at $18.88, -3.82% vs the prior close of $19.63. Day range $18.83–$19.78, opened at $19.50.
- Volume was 994.00K shares, 0.6x its 50-day average of 1.79M — lighter than usual.
- Price is +4.9% vs its 50-day average ($18.00) and +41.8% vs its 200-day average ($13.31).
- 52-week range $4.06–$21.24; today's close sits at 86% of that range, 11.1% below the 52-week high.
Oct 12, 2026 — OMER dips 1.0% to $19.63
- Closed at $19.63, -1.01% vs the prior close of $19.83. Day range $19.47–$20.24, opened at $19.74.
- Volume was 1.07M shares, 0.6x its 50-day average of 1.79M — lighter than usual.
- Price is +9.8% vs its 50-day average ($17.87) and +47.6% vs its 200-day average ($13.30).
- 52-week range $4.06–$21.24; today's close sits at 91% of that range, 7.6% below the 52-week high.
Oct 9, 2026 — OMER jumps 3.7% to $19.83, 3 up days in a row
- Closed at $19.83, +3.71% vs the prior close of $19.12. Day range $19.19–$19.91, opened at $19.20.
- Volume was 793.90K shares, 0.4x its 50-day average of 1.80M — lighter than usual.
- Price is +11.9% vs its 50-day average ($17.72) and +49.8% vs its 200-day average ($13.24).
- 52-week range $4.06–$21.24; today's close sits at 92% of that range, 6.6% below the 52-week high.
- That makes 3 straight gains.
Oct 8, 2026 — OMER rises 2.0% to $19.12
- Closed at $19.12, +1.97% vs the prior close of $18.75. Day range $18.41–$19.14, opened at $18.63.
- Volume was 899.90K shares, 0.5x its 50-day average of 1.82M — lighter than usual.
- Price is +8.9% vs its 50-day average ($17.56) and +45.0% vs its 200-day average ($13.19).
- 52-week range $4.06–$21.24; today's close sits at 88% of that range, 10.0% below the 52-week high.
Oct 7, 2026 — OMER rises 1.3% to $18.75
- Closed at $18.75, +1.30% vs the prior close of $18.51. Day range $18.02–$18.84, opened at $18.11.
- Volume was 622.90K shares, 0.3x its 50-day average of 1.85M — lighter than usual.
- Price is +7.7% vs its 50-day average ($17.41) and +42.7% vs its 200-day average ($13.14).
- 52-week range $4.06–$21.24; today's close sits at 86% of that range, 11.7% below the 52-week high.
Oct 6, 2026 — OMER dips 2.1% to $18.51
- Closed at $18.51, -2.06% vs the prior close of $18.90. Day range $18.31–$18.99, opened at $18.95.
- Volume was 1.03M shares, 0.5x its 50-day average of 1.90M — lighter than usual.
- Price is +7.2% vs its 50-day average ($17.26) and +41.4% vs its 200-day average ($13.09).
- 52-week range $4.06–$21.24; today's close sits at 84% of that range, 12.9% below the 52-week high.
Oct 5, 2026 — OMER rises 1.6% to $18.90
- Closed at $18.90, +1.56% vs the prior close of $18.61. Day range $18.55–$19.15, opened at $18.82.
- Volume was 1.07M shares, 0.6x its 50-day average of 1.89M — lighter than usual.
- Price is +10.4% vs its 50-day average ($17.12) and +44.9% vs its 200-day average ($13.05).
- 52-week range $4.06–$21.24; today's close sits at 86% of that range, 11.0% below the 52-week high.
Oct 2, 2026 — OMER rises 0.8% to $18.61
- Closed at $18.61, +0.76% vs the prior close of $18.47. Day range $18.22–$18.76, opened at $18.60.
- Volume was 956.40K shares, 0.5x its 50-day average of 1.90M — lighter than usual.
- Price is +9.9% vs its 50-day average ($16.94) and +43.2% vs its 200-day average ($12.99).
- 52-week range $4.06–$21.24; today's close sits at 85% of that range, 12.4% below the 52-week high.
OMER latest news & SEC filings
Every SEC filing by or about OMER in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Borges David J. converted options/RSUs into 5,000 shares at $3.93 (≈$19.65K) on Sep 22, 2026; now holds 5,000
- Borges David J. converted options/RSUs into 5,000 shares at $2.94 (≈$14.70K) on Sep 22, 2026; now holds 10,000
- Borges David J. sold 10,000 shares at $20.95 (≈$209.50K) on Sep 22, 2026
- Borges David J. converted options/RSUs into 10,000 shares at $15.58 (≈$155.80K) on Sep 23, 2026; now holds 10,000
- Borges David J. sold 10,000 shares at $20.95 (≈$209.50K) on Sep 23, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 23, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 22, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Cancelmo Peter B sold 25,000 shares at $18.54 (≈$463.50K) on Aug 31, 2026
- Cancelmo Peter B sold 25,000 shares at $18.65 (≈$466.25K) on Aug 28, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 31, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 28, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 13, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $28.53M (prior year $0)
- Net income: $13.23M (prior year -$25.42M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $0.15 (prior year -$0.43) (swung to profit vs Jun 30, 2025)
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 29, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 20, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jun 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Jun 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade OMER
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 31, 2026, Jan 7, 2026. Based on that rhythm, the next report is likely around Nov 11, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.69% (largest 13.8%).
- Liquidity: about 1.21M shares (≈$22.65M) trade per day on average.
- 52-week position: $18.79 vs a range of $6.24–$21.24 (84% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 14 sales; latest: David J. Borges sold 10,000 shares on Sep 23, 2026.
- Latest filings: 8-K Aug 13, 2026; 10-Q Aug 12, 2026; 8-K Aug 12, 2026.
- Share count: 72.39M shares outstanding (Aug 7, 2026), +6.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
OMER market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 18.50 | 19.08 | 18.30 | 18.79 | 931.40K |
| Oct 14, 2026 | 18.58 | 19.27 | 18.39 | 18.43 | 904.90K |
| Oct 13, 2026 | 19.50 | 19.78 | 18.83 | 18.88 | 994.00K |
| Oct 12, 2026 | 19.74 | 20.24 | 19.47 | 19.63 | 1.07M |
| Oct 9, 2026 | 19.20 | 19.91 | 19.19 | 19.83 | 793.90K |
| Oct 8, 2026 | 18.63 | 19.14 | 18.41 | 19.12 | 899.90K |
| Oct 7, 2026 | 18.11 | 18.84 | 18.02 | 18.75 | 622.90K |
| Oct 6, 2026 | 18.95 | 18.99 | 18.31 | 18.51 | 1.03M |
| Oct 5, 2026 | 18.82 | 19.15 | 18.55 | 18.90 | 1.07M |
| Oct 2, 2026 | 18.60 | 18.76 | 18.22 | 18.61 | 956.40K |
| Oct 1, 2026 | 18.87 | 19.20 | 18.47 | 18.47 | 1.24M |
| Sep 30, 2026 | 19.25 | 19.40 | 19.02 | 19.04 | 1.37M |
| Sep 29, 2026 | 19.26 | 19.57 | 19.00 | 19.25 | 841.70K |
| Sep 28, 2026 | 19.83 | 20.38 | 19.38 | 19.43 | 1.03M |
| Sep 25, 2026 | 20.39 | 20.61 | 19.66 | 20.08 | 942.00K |
| Sep 24, 2026 | 20.52 | 20.62 | 20.11 | 20.13 | 909.70K |
| Sep 23, 2026 | 20.65 | 20.97 | 20.43 | 20.74 | 1.35M |
| Sep 22, 2026 | 19.58 | 21.24 | 19.30 | 21.05 | 3.96M |
| Sep 21, 2026 | 18.23 | 18.51 | 17.82 | 18.49 | 1.06M |
| Sep 18, 2026 | 18.69 | 18.69 | 17.68 | 17.87 | 2.15M |
About Omeros
Omeros (OMER) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SEATTLE, WA. State of incorporation: WA. Fiscal year ends December 31. SEC CIK 1285819.
OMER board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Thomas F. Bumol | Director | Jun 22, 2026 |
| Thomas J. Cable | Director | Aug 21, 2026 |
| Gregory A Md Demopulos | Chairman, CEO & President | Jul 24, 2026 |
| Peter A Md Demopulos | Director | Jun 22, 2026 |
| Arnold C Hanish | Director | Aug 28, 2026 |
| Leroy E. Md Phd Hood | Director | Jun 22, 2026 |
| Diana T. Perkinson | Director | Jun 22, 2026 |
| Joseph L Schocken | Director | Aug 18, 2026 |
| Rajiv Shah | Director | Jun 22, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| David J. Borges | VP, Finance & CAO | Sep 24, 2026 |
| Peter B Cancelmo | VP, General Counsel | Sep 1, 2026 |
| Gregory A Md Demopulos | Chairman, CEO & President | Jul 24, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 23, 2026 | David J. Borges | Sale | 10,000 | $20.95 |
| Sep 22, 2026 | David J. Borges | Sale | 10,000 | $20.95 |
| Aug 31, 2026 | Peter B Cancelmo | Sale | 25,000 | $18.54 |
| Aug 28, 2026 | Peter B Cancelmo | Sale | 25,000 | $18.65 |
| Aug 27, 2026 | Arnold C Hanish | Sale | 5,000 | $19.02 |
| Aug 27, 2026 | Arnold C Hanish | Sale | 5,000 | $18.88 |
| Aug 26, 2026 | Arnold C Hanish | Sale | 5,000 | $18.53 |
| Aug 24, 2026 | David J. Borges | Sale | 906 | $19.10 |
| Aug 21, 2026 | David J. Borges | Sale | 10,000 | $18.95 |
| Aug 20, 2026 | Thomas J. Cable | Sale | 15,000 | $18.45 |
| Aug 13, 2026 | David J. Borges | Sale | 5,000 | $16.95 |
| May 22, 2026 | Thomas J. Cable | Sale | 7,500 | $11.61 |
| Jan 13, 2026 | David J. Borges | Sale | 30,000 | $12.31 |
| Jan 12, 2026 | David J. Borges | Sale | 30,000 | $12.72 |
OMER financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-3.35M | -0.05 | $-116.09M |
| Dec 31, 2024 | — | $-156.81M | -2.70 | $-148.80M |
| Dec 31, 2023 | — | $-117.81M | -1.88 | $74.73M |
| Dec 31, 2022 | — | $47.42M | 0.76 | $-86.48M |
| Dec 31, 2021 | — | $194.24M | 3.12 | $-109.72M |
Latest balance sheet: total assets $286.83M, total liabilities $—, cash $1.99M (as of Jun 30, 2026).
OMER earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $13.71 |
| May 13, 2026 | 8-K Item 2.02 (results) | $14.38 |
| Mar 31, 2026 | 8-K Item 2.02 (results) | $10.56 |
| Jan 7, 2026 | 8-K Item 2.02 (results) | $14.09 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $6.28 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $4.12 |
| May 15, 2025 | 8-K Item 2.02 (results) | $3.95 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $8.22 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $4.19 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 15, 2024 | 8-K Item 2.02 (results) | — |
| Apr 1, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on OMER
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.